BMP-7: A future treatment for chronic renal failure?;La «bone morphogenic protein 7» (BMP-7): Un espoir dans le traitement de l'insuffisance rénale chronique

Revue Medicale Suisse

Volumn 1, Issue 8, 2005, Pages 568-573

  Niksic, Laurent ^a   Martin, Pierre Yves ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

OSTEOGENIC PROTEIN 1; TRANSFORMING GROWTH FACTOR BETA; BONE MORPHOGENETIC PROTEIN;

APOPTOSIS; CHRONIC KIDNEY FAILURE; DIABETIC NEPHROPATHY; DRUG MECHANISM; EPITHELIUM CELL; KIDNEY FIBROSIS; KIDNEY FUNCTION; NONHUMAN; PHENOTYPE; RENAL PROTECTION; REVIEW; FIBROSIS; HUMAN; PATHOLOGY; URETER OBSTRUCTION;

BONE MORPHOGENETIC PROTEINS; DIABETIC NEPHROPATHIES; FIBROSIS; HUMANS; KIDNEY FAILURE, CHRONIC; TRANSFORMING GROWTH FACTOR BETA; URETERAL OBSTRUCTION;

EID: 18344375299     PISSN: 16609379     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (36)

1. Remuzzi G, Bertani T. Pathophysiology of progressive nephropathies. N Engl J Med 1998;339:1448-56.
2. Brenner BM, Meyer TW, Hostetter TH. Dietary protein intake and the progressive nature of kidney disease: The role of hemodynamically mediated glomerular injury in the pathogenesis of progressive glomerular sclerosis in aging, renal ablation, and intrinsic renal disease. N Engl J Med 1982;307:652-9.
3. Border WA, Okuda S, Languino LR, et al. Suppression of experimental glomerulonephritis by antiserum against transforming growth factor beta 1. Nature 1990;346:371-4.
4. Klahr S, Morrissey JJ. Obstructive nephropathy and renal fibrosis. Am J Physiol Renal Physiol 2002;283: F861-75.
5. Vukicevic S, Basic V, Rogic D, et al. Osteogenic protein-1 (bone morphogenetic protein-7) reduces severity of injury after ischemic acute renal failure in rat. J Clin invest 1998;102:202-14.
6. Hruska K, Guo G, Wozniak M, et al. Osteogenic protein-1 prevents renal fibrogenesis associated with ureteral obstruction. Am J Physiol (Renal) 2000;279: F130-F43.
7. Zeisberg M, Hanai J, Sugimoto H, et al. BMP-7 counteracts TGF β-1 induced epithelial-to-mesenchymal transition and reverses chronic renal injury. Nat Med 2003;9:964-8.
8. Wang S, Chen Q, Simon TC, et al. Bone morphogenetic protein-7 (BMP-7), a novel therapy for diabetic nephropathy. Kidney Int 2003;63:2037-49.
9. Zeisberg M, Bottiglio C, Kumar N, et al. Bone morphogenetic protein-7 inhibits progression of chronic renal fibrosis associated with two genetic mouse models. Am J Physiol (Renal) 2003;285:F1060-7.
10. Sharma K, Eltayeb BO, McGowan TA, et al. Captopril-induced reduction of serum levels of transforming growth factor-beta 1 correlates with long-term renoprotection in insulin-dependent diabetic patients. Am J Kidney Dis 1999;34:818-23.
11. Border WA, Noble NA. Targeting TGF-beta for treatment of disease. Nat Med 1996;1:1000-1.
12. Kopp JB, Factor VM, Mozes M et al. Transgenic mice with increased plasma levels of TGF-beta 1 develop progressive renal disease. Lab Invest 1996;74:991-1003.
13. Ziyadeh FN, Hoffman BB, Han DC, et al. Long-term prevention of renal insufficiency, excess matrix gene expression, and glomerular mesangial matrix expansion by treatment with monoclonal antitransforming growth factor-beta antibody in db/db diabetic mice. Proc Natl Acad Sci USA 2000;97:8015-20.
14. Zeisberg M, Ericksen MB, Hamano Y, et al. Differential expression of type IV collagen isoforms in rat glomerular endothelial and mesangial cells. Biochem Biophys Res Commun 2002;295:401-7.
15. Muller GA, Zeisberg M, Strutz F. The importance of tubulointerstitial damage in progressive renal disease. Nephrol Dial Transplant 2000;15:76-7.
16. Zeisberg M, Strutz F, Muller GA. Renal fibrosis:An update. Curr Opin Nephrol Hypertens 2001;10:315-20.
17. Iwano M, Plieth D, Danoff TM, et al. Ece that fibroblasts derive from epithelium during tissue fibrosis. J Clin Invest 2002;110:341-50.
18. Almanzar MM, Frazier KS, Dube PH, et al. Osteogenic protein-1 mRNA expression is selectively modulated after acute ischemic renal injury. J Am Soc Nephrol 1998;9:1456-63.
19. Feinberg MW, Shimizu K, Lebedeva M, et al. Essential role for Smad3 in regulating MPC-1 expression and vascular inflammation. Circ Res 2004;94:601-8.
20. Wang AE, Rosen V, Cordes P. Purification and characterization of other distinct bone-inducing factors. Proc Natl Acad Sci USA 1988;85:9484-8.
21. Dudley A, Lyons M, Robertson E. A requirement for bone morphogenic protein-7 during development of the mammalian kidney and eye. Genes Dev 1995;9:2795-807.
22. Vukicevic S, Kopp JB, Luyten F, et al. Induction of nephrogenic mesenchyme by osteogenic protein 1a 7 (bone morphogenic protein a 7). Proc Natl Acad Sci USA 1996;93:9021-6.
23. Luo G, Hofmann C, Bronckers AI, et al. BMP-7 is inducers of nephrogenesis, and is also required for eye development and skeletal patterning. Genes Dev 1995;9:2808-20.
24. Wang S, La Page J, Hirschberg R. Loss of tubular bone morphogenetic protein-7 in diabetic nephropathy. J Am Soc Nephrol 2001;12:2392-9.
25. Simon M, Maresh JG, Harris SE, et al. Expression of bone morphogenetic protein-7 mRNA in normal and ischemic adult rat kidney. Am J Physiol 1999;276:F382-9.
26. Reeves WB, Andreoli TE. Transforming growth factor beta contributes to progressive diabetic nephropathy. Proc Natl Acad Sci USA 2000;97:7667-9.
27. Ziyadeh F N. Mediators of diabetic renal disease: The case of TGF-β as the major mediator. J Am soc Nephrol 2004;15(Suppl.):S55-S7.
28. Isaka Y, Tsujie M, Ando Y, et al. Transforming growth factor-beta-1 antisense oligodeoxynucleotides block interstitial fibrosis in unilateral ureteral obstruction. Kidney Int 2000;58:1885-92.
29. Miyajima A, Chen J, Lawrence C, et al. Antibody to transforming growth factor-beta ameliorates tubular apoptosis in unilateral ureteral obstruction. Kidney Int 2000;58:2301-13.
30. Kaneto H, Ohtani H, Fukuzaki A, et al. Increased expression of TGF-beta 1 but not of its receptors contributes to human obstructive nephropathy. Kidney Int 1999;56:2137-46.
31. Liu Y. Epithelial to mesenchymal transition in renal fibrogenesis: pathologic significance, molecular mechanism, and therapeutic intervention. J Am Soc Nephrol 2004;15:1-12.
32. Wang S, Hirschberg R. BMP7 antagonizes TGF-beta-dependent fibrogenesis in mesangial cells. Am J Physiol (Renal) 2003;284:F1006-13.
33. Postigo AA. Opposing functions of ZEB proteins in the regulation of the TGFB/BMP signaling pathway. EMBO J 2003;22:2443-52.
34. Imamura T, Takase M, Nishihara A, et al. Smad6 inhibits signalling by the TGF-β super-family. Nature 1997;389:622-6.
35. Nakao A, Afrakhte M, Morn A, et al. Identification of Smad7, a TGF-β inducible antagonist of TGF-β signalling. Nature 1997;389:631-5.
36. Li T, Surendran K, Zawaideh MA, et al. Bone morphogenetic protein 7:A novel treatment for chronic renal and bone disease. Current Opin Nephrol Hypertension 2004;13:417-22.